Roche Holding is testing a cost-sharing program with provincial governments in China that could make cancer drugs accessible to more people. Under the deal, Roche donates eight vials of its breast cancer drug Herceptin to patients after they have purchased six vials of the drug, which the provincial government has begun subsidizing. The drug is not covered by China's public health insurance program, but the number of patients in China taking the drug quadrupled in 2012, thanks in part to the cost-sharing arrangement.

Full Story:

Related Summaries